Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse

Yan Tang, Haruhiko Osawa, Hiroshi Onuma, Tatsuya Nishimiya, Masaaki Ochi, Atsuro Sugita, Hideichi Makino

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Phosphodiesterase (PDE) 3B, when activated by insulin, causes a decrease in intracellular cAMP concentration. The activation of this enzyme results in the reduced output of free fatty acids (FFA) from adipocytes, and an increased lipogenesis in liver. We have recently shown that PDE3B gene expression is reduced in adipose tissues of KKAy mice. We intend to further elucidate the regulation of PDE3B in liver as well as adipose tissues in relation to the insulin resistant state. We examined PDE3B gene expression in liver and adipose tissues of obese, insulin-resistant diabetic db/db mice and also checked the effect of an insulin-sensitizing drug, troglitazone, on this gene expression. In the liver of db/db mice, PDE3B mRNA, its corresponding protein, and the associated catalytic activity were all increased by 2.1, 1.9 and 1.6-fold, respectively, over those in db/+ control mice. Histological examination revealed substantial triglyceride storage in the liver of db/db mice. Conversely, in the adipose tissue of db/db mice, PDE3B mRNA, protein, and its associated activity were all decreased by 0.38, 0.33 and 0.36-fold, respectively. Troglitazone, which has no effect on PDE3B in liver, increased the expression of this gene in adipocytes. This increase is associated with a reduction in the elevated levels of serum insulin, glucose, FFA and triglycerides. The reduced PDE3B gene expression in adipose tissues, which results in the elevation of serum FFA, could be the primary event in the development of insulin resistance in db/db mice. The enhanced PDE3B gene expression may correlate with changes in triglyceride storage in the liver of these mice.

Original languageEnglish (US)
Pages (from-to)145-155
Number of pages11
JournalDiabetes Research and Clinical Practice
Volume54
Issue number3
DOIs
StatePublished - Nov 10 2001
Externally publishedYes

Fingerprint

Type 3 Cyclic Nucleotide Phosphodiesterases
Adipose Tissue
Insulin
Gene Expression
Liver
troglitazone
Nonesterified Fatty Acids
Triglycerides
Adipocytes
Messenger RNA
Lipogenesis
Enzyme Activation
Serum
Insulin Resistance
Proteins
Glucose

Keywords

  • Adipocyte
  • Gene expression
  • Liver
  • Phosphodiesterase 3B
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse. / Tang, Yan; Osawa, Haruhiko; Onuma, Hiroshi; Nishimiya, Tatsuya; Ochi, Masaaki; Sugita, Atsuro; Makino, Hideichi.

In: Diabetes Research and Clinical Practice, Vol. 54, No. 3, 10.11.2001, p. 145-155.

Research output: Contribution to journalArticle

Tang, Yan ; Osawa, Haruhiko ; Onuma, Hiroshi ; Nishimiya, Tatsuya ; Ochi, Masaaki ; Sugita, Atsuro ; Makino, Hideichi. / Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse. In: Diabetes Research and Clinical Practice. 2001 ; Vol. 54, No. 3. pp. 145-155.
@article{6be0da9731764295b993955a79969d18,
title = "Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse",
abstract = "Phosphodiesterase (PDE) 3B, when activated by insulin, causes a decrease in intracellular cAMP concentration. The activation of this enzyme results in the reduced output of free fatty acids (FFA) from adipocytes, and an increased lipogenesis in liver. We have recently shown that PDE3B gene expression is reduced in adipose tissues of KKAy mice. We intend to further elucidate the regulation of PDE3B in liver as well as adipose tissues in relation to the insulin resistant state. We examined PDE3B gene expression in liver and adipose tissues of obese, insulin-resistant diabetic db/db mice and also checked the effect of an insulin-sensitizing drug, troglitazone, on this gene expression. In the liver of db/db mice, PDE3B mRNA, its corresponding protein, and the associated catalytic activity were all increased by 2.1, 1.9 and 1.6-fold, respectively, over those in db/+ control mice. Histological examination revealed substantial triglyceride storage in the liver of db/db mice. Conversely, in the adipose tissue of db/db mice, PDE3B mRNA, protein, and its associated activity were all decreased by 0.38, 0.33 and 0.36-fold, respectively. Troglitazone, which has no effect on PDE3B in liver, increased the expression of this gene in adipocytes. This increase is associated with a reduction in the elevated levels of serum insulin, glucose, FFA and triglycerides. The reduced PDE3B gene expression in adipose tissues, which results in the elevation of serum FFA, could be the primary event in the development of insulin resistance in db/db mice. The enhanced PDE3B gene expression may correlate with changes in triglyceride storage in the liver of these mice.",
keywords = "Adipocyte, Gene expression, Liver, Phosphodiesterase 3B, Type 2 diabetes",
author = "Yan Tang and Haruhiko Osawa and Hiroshi Onuma and Tatsuya Nishimiya and Masaaki Ochi and Atsuro Sugita and Hideichi Makino",
year = "2001",
month = "11",
day = "10",
doi = "10.1016/S0168-8227(01)00271-6",
language = "English (US)",
volume = "54",
pages = "145--155",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse

AU - Tang, Yan

AU - Osawa, Haruhiko

AU - Onuma, Hiroshi

AU - Nishimiya, Tatsuya

AU - Ochi, Masaaki

AU - Sugita, Atsuro

AU - Makino, Hideichi

PY - 2001/11/10

Y1 - 2001/11/10

N2 - Phosphodiesterase (PDE) 3B, when activated by insulin, causes a decrease in intracellular cAMP concentration. The activation of this enzyme results in the reduced output of free fatty acids (FFA) from adipocytes, and an increased lipogenesis in liver. We have recently shown that PDE3B gene expression is reduced in adipose tissues of KKAy mice. We intend to further elucidate the regulation of PDE3B in liver as well as adipose tissues in relation to the insulin resistant state. We examined PDE3B gene expression in liver and adipose tissues of obese, insulin-resistant diabetic db/db mice and also checked the effect of an insulin-sensitizing drug, troglitazone, on this gene expression. In the liver of db/db mice, PDE3B mRNA, its corresponding protein, and the associated catalytic activity were all increased by 2.1, 1.9 and 1.6-fold, respectively, over those in db/+ control mice. Histological examination revealed substantial triglyceride storage in the liver of db/db mice. Conversely, in the adipose tissue of db/db mice, PDE3B mRNA, protein, and its associated activity were all decreased by 0.38, 0.33 and 0.36-fold, respectively. Troglitazone, which has no effect on PDE3B in liver, increased the expression of this gene in adipocytes. This increase is associated with a reduction in the elevated levels of serum insulin, glucose, FFA and triglycerides. The reduced PDE3B gene expression in adipose tissues, which results in the elevation of serum FFA, could be the primary event in the development of insulin resistance in db/db mice. The enhanced PDE3B gene expression may correlate with changes in triglyceride storage in the liver of these mice.

AB - Phosphodiesterase (PDE) 3B, when activated by insulin, causes a decrease in intracellular cAMP concentration. The activation of this enzyme results in the reduced output of free fatty acids (FFA) from adipocytes, and an increased lipogenesis in liver. We have recently shown that PDE3B gene expression is reduced in adipose tissues of KKAy mice. We intend to further elucidate the regulation of PDE3B in liver as well as adipose tissues in relation to the insulin resistant state. We examined PDE3B gene expression in liver and adipose tissues of obese, insulin-resistant diabetic db/db mice and also checked the effect of an insulin-sensitizing drug, troglitazone, on this gene expression. In the liver of db/db mice, PDE3B mRNA, its corresponding protein, and the associated catalytic activity were all increased by 2.1, 1.9 and 1.6-fold, respectively, over those in db/+ control mice. Histological examination revealed substantial triglyceride storage in the liver of db/db mice. Conversely, in the adipose tissue of db/db mice, PDE3B mRNA, protein, and its associated activity were all decreased by 0.38, 0.33 and 0.36-fold, respectively. Troglitazone, which has no effect on PDE3B in liver, increased the expression of this gene in adipocytes. This increase is associated with a reduction in the elevated levels of serum insulin, glucose, FFA and triglycerides. The reduced PDE3B gene expression in adipose tissues, which results in the elevation of serum FFA, could be the primary event in the development of insulin resistance in db/db mice. The enhanced PDE3B gene expression may correlate with changes in triglyceride storage in the liver of these mice.

KW - Adipocyte

KW - Gene expression

KW - Liver

KW - Phosphodiesterase 3B

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=0034748311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034748311&partnerID=8YFLogxK

U2 - 10.1016/S0168-8227(01)00271-6

DO - 10.1016/S0168-8227(01)00271-6

M3 - Article

C2 - 11689269

AN - SCOPUS:0034748311

VL - 54

SP - 145

EP - 155

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 3

ER -